Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
about
¹⁸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data.Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer.Posttherapy residual disease associates with long-term survival after chemoradiation for bulky stage 1B cervical carcinoma: a Gynecologic Oncology Group study.18F-FDG PET/CT imaging in oncologyPositron emission tomography in gynecological malignancies.PET and PET-CT imaging of gynecological malignancies: present role and future promise.Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer.Functional imaging for assessing tumor response in cancer of the cervix.Role of PET-CT Scan in Gynaeconcology.Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma.Positron emission tomography with the glucose analog [F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: comparison with CT and MRI findings.The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings.Survival outcomes in patients with cervical cancer after inclusion of PET/CT in staging procedures.Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation.Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy.Clinical Value of Combining F-FDG PET/CT and Routine Serum Tumor Markers in The Early Detection of Recurrence Among Follow-up Patients Treated for Cervical Squamous Cell Carcinoma
P2860
Q30980315-42037C36-1059-4C36-AC4F-88A3059E8956Q34123402-BF860D0D-0A03-4BDB-880C-3F2CDB55BE04Q34163791-DC9296E9-5845-4240-980F-9F671B837BB0Q35006097-D91EA8F8-45FC-4627-ACC5-997D76C24961Q36532097-AD90C2E8-E217-4D8E-B2D9-A692EC0B9556Q37357297-A5303E55-9D0D-4A6B-9A85-8A7EEFB27EF8Q37848781-AC8D29CD-A26C-47EF-A3AB-142CC295E473Q37905821-52ABB54B-9A7F-446F-B8C4-DEDAF39AA0D2Q41651165-E85418EE-CCA8-411A-BFFD-D4837963B45CQ43122515-5361371C-1D61-4783-957F-CA17CEF34BDCQ46122881-134B2885-9FBF-42D8-8F22-CA5D181BEF7FQ46818567-0276EC07-52C7-4965-B357-C4A193B37636Q48985900-4D36DA69-C814-4621-90A6-940D96F72C30Q50961775-1D80DD9C-8F81-4485-A174-DBCA6D661C31Q52794306-218C926A-5161-4FD6-AE52-5707F9187A62Q53094712-66125EBF-9035-43BC-9C7B-67FAD45389E5Q58798374-FB499696-5669-479C-A2CB-5DBCB887CAF4
P2860
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
@ast
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
@en
type
label
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
@ast
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
@en
prefLabel
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
@ast
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
@en
P2093
P1476
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
@en
P2093
Barry A Siegel
David G Mutch
Farrokh Dehdashti
Perry W Grigsby
P304
P356
10.1016/S0360-3016(02)04287-6
P407
P577
2003-03-01T00:00:00Z